Evidence map›Paper›PMID 35407220›Full record

ReviewNanomaterials (Basel, Switzerland)2022

Application of Green Gold Nanoparticles in Cancer Therapy and Diagnosis.

Saman Sargazi, Ushna Laraib, Simge Er, Abbas Rahdar, Mohadeseh Hassanisaadi, Muhammad Nadeem Zafar, Ana M Díez-Pascual, Muhammad Bilal

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 168 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Eco-friendly Cu-TiOAMB Express · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 5 countries.

Saman SargaziCellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan 98167-43463, Iran.ORCID 0000-0002-2255-5977
Ushna LaraibDepartment of Pharmacy, College of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
Simge ErDepartment of Biochemistry, Faculty of Science, Ege University, Izmir 35100, Turkey.ORCID 0000-0002-5814-0618
Abbas RahdarDepartment of Physics, University of Zabol, Zabol P.O. Box 98613-35856, Iran.ORCID 0000-0003-4766-9214
Mohadeseh HassanisaadiDepartment of Plant Protection, Shahid Bahonar University of Kerman, Kerman 76184-11764, Iran.ORCID 0000-0002-5626-6583
Muhammad Nadeem ZafarDepartment of Chemistry, University of Gujrat, Gujrat 50700, Pakistan.ORCID 0000-0002-2109-7601
Ana M Díez-PascualUniversidad de Alcalá, Facultad de Ciencias, Departamento de Química Analítica, Química Física e Ingeniería Química, Ctra. Madrid-Barcelona, Km. 33.6, Alcalá de Henares, 28805 Madrid, Spain.ORCID 0000-0001-7405-2354
Muhammad BilalHuaiyin Institute of Technology, School of Life Science and Food Engineering, Huaian 223003, China.ORCID 0000-0001-5388-3183
Ege University · TRHuaiyin Institute of Technology · CNShahid Bahonar University of Kerman · IRUniversidad de Alcalá · ESUniversity of Gujrat · PKUniversity of Sargodha · PKZabol University · IRZahedan University of Medical Sciences · IR

Funding

Community of Madrid EPU-INV/2020/012
6 · The paper itself

Abstract

Nanoparticles are currently used for cancer theranostics in the clinical field. Among nanoparticles, gold nanoparticles (AuNPs) attract much attention due to their usability and high performance in imaging techniques. The wide availability of biological precursors used in plant-based synthesized AuNPs allows for the development of large-scale production in a greener manner. Conventional cancer therapies, such as surgery and chemotherapy, have significant limitations and frequently fail to produce satisfying results. AuNPs have a prolonged circulation time, allow easy modification with ligands detected via cancer cell surface receptors, and increase uptake through receptor-mediated endocytosis. To exploit these unique features, studies have been carried out on the use of AuNPs as contrast agents for X-ray-based imaging techniques (i.e., computed tomography). As nanocarriers, AuNPs synthesized by nontoxic and biocompatible plants to deliver therapeutic biomolecules could be a significant stride forward in the effective treatment of various cancers. Fluorescent-plant-based markers, including AuNPs, fabricated using

Indexed as

biosynthesisgold nanoparticlesgreen synthesisleaf extractsurface plasmon resonancetoxicity

Identifiers

PMID35407220
PMCPMC9000429
OpenAlexW4221022112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.